Loading...
Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma
Lung squamous cell carcinoma (LUSC) is the second major type of lung cancer globally. The majority of patients with LUSC are clinically diagnosed at the advanced stages, thus it is urgent to identify suitable prognostic markers for LUSC. B-cell lymphoma 2 (Bcl-2) has been widely studied in non-small...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920356/ https://ncbi.nlm.nih.gov/pubmed/29725421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8198 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|